Showing results 1 to 9 of approximately 9.(refine search)
Does locale affect R&D productivity? the case of pharmaceuticals
Regional economy and manufacturing update
Remarks at the Quarterly Regional Economic Press Briefing, New York City.
A note on global walfare in pharmaceutical patenting
This paper revisits the question of whether global welfare is higher under a uniform world-wide system of pharmaceutical product patents or with international rules allowing low-income nations to free-ride on the discoveries of firms in rich nations. Key variables include the extent to which free-riding reduces the discovery of new drugs, the rent potential of rich as compared to poor nations, the ratio of the marginal utility of income in poor as compared to rich nations, and the competitive environment within which R&D decisions are made. Global welfare is found to be higher with ...
What the doctor ordered? : the economics of drug reimportation
Filling a prescription for more pharmacies
Across the country and the district, pharmacy schools look like the equivalent of a 90-day refill?a good supply, at least for the time being.
Innovations are changing how, where and when people receive pharmacy services. Not everyone is thrilled.
Too much of a good thing can be bad: the pros and cons of pharmaceutical patents
Pharmaceutical firms-and society-depend on patent protection to foster the development of new drugs. But patents also raise prices and reduce access by delaying generic competition.
Cash, check or third party?
Prescription benefit plans are squeezing retail pharmacies.
The other pharm crisis
The pharmacy industry faces a multitude of challenges, and rural areas confront the possibility of losing pharmacy services.